Stigmalactam is primarily investigated for its potential bioactive properties, particularly in pharmaceutical research. It has shown promise as a scaffold in the development of novel therapeutic agents due to its unique lactam structure fused with a steroidal framework. This compound exhibits modulatory effects on certain enzymatic activities, making it a candidate for use in anti-inflammatory and neuroprotective agents. Preliminary studies suggest possible applications in treating metabolic and hormonal disorders owing to its structural similarity to endogenous steroids. Additionally, stigmalactam derivatives are explored in medicinal chemistry for their ability to enhance drug selectivity and bioavailability. Research is ongoing to fully exploit its utility in drug design and development.